About

Dr. Ya Lu is a leading voice in evidence-based surgical oncology, specializing in the comparative effectiveness of minimally invasive techniques for urologic and colorectal cancers. Her work is defined by rigorous systematic reviews and meta-analyses that directly inform clinical decision-making. Dr. Lu’s major contributions include pioneering Bayesian network analyses that compare open, laparoscopic, and robot-assisted radical cystectomy for bladder cancer, providing critical insights into both perioperative safety and long-term oncologic outcomes. She has also conducted landmark meta-analyses evaluating transanal total mesorectal excision for rectal cancer and comparing minimally invasive partial nephrectomy against focal therapy for small renal masses. Her research consistently addresses pressing clinical debates, such as the role of minimally invasive proctectomy for locally advanced colon cancer. With several of her key papers accumulating 5–7 citations each within a short time, Dr. Lu’s work is already shaping the evidence base for modern surgical practice. Her ability to synthesize complex data through advanced statistical methods makes her a vital resource for surgeons and researchers seeking clarity on the optimal surgical approaches for cancer patients.

Research Focus

Key Achievements

4
H-Index
5
Papers
26
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
A systematic review and meta-analysis of minimally invasive total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer
7 citations · 2023
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: First Affiliated Hospital of Chengdu Medical College, Chengdu Medical College, Adaptive Design Association

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago